Crinetics Pharmaceuticals, Inc. (CRNX) Stock News & Chart

(CRNX)

Crinetics Pharmaceuticals, Inc.

Stock chart and latest news for Crinetics Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Crinetics Pharmaceuticals, Inc. News

PRO

Stock Titan

CRNX (NASDAQ: CRNX) files Rule 144: 20,900-share exercise, prior 10b5-1 sales

Apr 14, 2026 Yahoo Finance

Is Crinetics Pharmaceuticals (CRNX) Pricing Reflect Its Sharp Swings And DCF Upside Potential

Mar 14, 2026 Quiver Quantitative

Crinetics Pharmaceuticals Prices Public Offering of 7.62 Million Shares at $45.95 Each, Anticipating $350 Million in Proceeds

Jan 7, 2026 Stock Titan

Insider Sales: CRNX (NASDAQ: CRNX) 4,434-share option sale; Knight 95,074 prior shares

Apr 13, 2026 Yahoo Finance

Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug

Feb 18, 2026 Stock Titan

Crinetics (CRNX) COO exercises options and sells 85,163 shares under 10b5-1

Apr 10, 2026 Yahoo Finance

Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Jan 15, 2026 Stock Titan

Crinetics sets May 7 earnings call, business update after close

Apr 8, 2026 Yahoo Finance

JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval

Sep 30, 2025 Stock Titan

Jeff Knight exits Crinetics (NASDAQ: CRNX) officer role, stays on under paid consulting deal

Apr 10, 2026 Yahoo Finance

Those who invested in Crinetics Pharmaceuticals (NASDAQ:CRNX) five years ago are up 151%

Sep 18, 2025 Stock Titan

Insider sale: CRNX (NASDAQ: CRNX) files Form 144 for 9,911 shares on 03/16/2026

Apr 8, 2026